Twist Bioscience collaborates with Synthetic Design Lab

CAR-T Digest - August 2020

02 September 2025: Twist Bioscience collaborates with Synthetic Design Lab

Twist Bioscience announced a collaboration with Synthetic Design Lab (SDL) to develop novel antibody-drug conjugates (ADCs) for cancer
Twist will apply its high-throughput discovery and screening expertise to support SDL’s therapeutic programs
SDL aims to use its SYNTHBODY platform to create more advanced therapeutics than currently available
The partnership leverages Twist’s proprietary tools and platform for specific research activities
Both companies expect the collaboration to accelerate the advancement of engineered cancer therapeutics